Clinical Trials
We are always on the lookout for participants for our clinical trials, in the areas of Type 2 Diabetes, Insomnia, Obesity and Anxiety. Please click on the relative links below to apply and find out more information.
Post-Traumatic Stress Disorder (PTSD)
Post-Traumatic Stress Disorder (PTSD) is a common psychiatric disorder that develops following exposure to a traumatic event and is associated with several health consequences, such as acute stress and anxiety disorders and sleep disturbances or insomnia. We are actively recruiting for a Clinical Trial that uses the Modius Spero Trial Device which is indicated to manage PTSD symptoms through the action of Cranial Electrotherapy Stimulation being delivered to the head in a non-invasive way that has been shown to be both safe and effective across multiple populations.
Primary Outcomes:
Reduce stress & improve sleep
Locations:
Remote US Trial,
UCSD
Duration:
12 Weeks
Status:
Actively Recruiting
Anxiety
We are actively recruiting for a fully remote (participants can fully participate from home) Clinical Trial to evaluate the Efficacy of Electrical Vestibular Stimulation (VeNS), for The Management of Anxiety.
Primary Outcomes:
Reduced stress & anxiety
Locations:
Belfast,
Northern Ireland
Duration:
4 Weeks
Status:
Actively Recruiting
Adults with Type 2 Diabetes
Electrical vestibular nerve stimulation (VeNS) compared to sham control as a means of improving glycemic control in adults with Type 2 Diabetes mellitus. In a 16-week study with type 2 diabetic patients, our Vestal DM technology demonstrated a 0.4% reduction in HbA1c.
Primary Outcomes:
HbA1c reduction
Location:
ActivMed Research,
Methuen,
Massachusetts
Duration:
24 Weeks
Status:
Actively Recruiting
Primary Outcomes:
HbA1c reduction
Location:
Adult Medicine of Lake County,
Mount Dora,
Florida
Duration:
24 Weeks
Status:
Actively Recruiting
Primary Outcomes:
HbA1c reduction
Location:
ActivMed Research,
Portsmouth,
New Hampshire
Duration:
24 Weeks
Status:
Actively Recruiting
Primary Outcomes:
HbA1c reduction
Location:
Billings Clinic,
Billings,
Montana
Duration:
24 Weeks
Status:
Actively Recruiting
Primary Outcomes:
HbA1c reduction
Location:
Charlottesville Medical Research,
Virginia
Duration:
24 Weeks
Status:
Actively Recruiting
Primary Outcomes:
HbA1c reduction
Locations:
The Exercise and Physical Activity Resource Center (EPARC),
San Diego
Duration:
24 Weeks
Status:
Actively Recruiting
Primary Outcomes:
HbA1c reduction
Locations:
Complete Health Partners,
Nashville,
Tennessee
Duration:
24 Weeks
Status:
Actively Recruiting
Primary Outcomes:
HbA1c reduction
Location:
NCMR Medical Research Centre,
Sacramento
Duration:
24 Weeks
Status:
Actively Recruiting
Primary Outcomes:
HbA1c reduction
Location:
Ichan School of Medicine,
Mount Sinai,
New York
Duration:
24 Weeks
Status:
Actively Recruiting
Primary Outcomes:
HbA1c reduction
Location:
Oviedo Medical Research Centre,
Florida
Duration:
24 Weeks
Status:
Actively Recruiting
Primary Outcomes:
HbA1c reduction
Location:
RGV Endocrine Center,
McAllen,
Texas
Duration:
24 Weeks
Status:
Actively Recruiting
Primary Outcomes:
HbA1c reduction
Location:
South Florida Research Organisation,
Miami,
Florida
Duration:
24 Weeks
Status:
Actively Recruiting
Primary Outcomes:
HbA1c reduction
Locations:
Department of Nutrition Sciences,
University of Alabama,
Birmingham,
Alabama
Duration:
24 Weeks
Status:
Actively Recruiting
Primary Outcomes:
HbA1c reduction
Location:
University College Dublin,
Ireland
Duration:
24 Weeks
Status:
Actively Recruiting
